Clinical Trial Update: Phase II Trial of BrECADD in HIV-Positive Patients With Advanced-Stage Classical Hodgkin Lymphoma [Phase 2]

View source ↗

Summary

Phase II trial investigating BrECADD in HIV-positive patients with advanced classical Hodgkin lymphoma; status not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• BrECADD

Snippet

Sponsor: University of Cologne | Conditions: Hodgkin Lymphoma (Category) | Phase 2 | Status: NOT_YET_RECRUITING